136 related articles for article (PubMed ID: 7949198)
1. Second cancer risk after interferon therapy?
Troussard X; Henry-Amar M; Flandrin G
Blood; 1994 Nov; 84(9):3242-4. PubMed ID: 7949198
[No Abstract] [Full Text] [Related]
2. Interferon in the treatment of hairy-cell leukemia.
Ahmed S; Rai KR
Best Pract Res Clin Haematol; 2003 Mar; 16(1):69-81. PubMed ID: 12670466
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.
Flinn IW; Kopecky KJ; Foucar MK; Head D; Bennett JM; Hutchison R; Corbett W; Cassileth P; Habermann T; Golomb H; Rai K; Eisenhauer E; Appelbaum F; Cheson B; Grever MR
Blood; 2000 Nov; 96(9):2981-6. PubMed ID: 11049974
[TBL] [Abstract][Full Text] [Related]
4. Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature.
Al-Fiar F; Meharchand J; Curtis J; Lipton JH
Leuk Res; 1999 Aug; 23(8):719-21. PubMed ID: 10456669
[TBL] [Abstract][Full Text] [Related]
5. Second malignancy in hairy cell leukaemia: no evidence of increased incidence after treatment with interferon alpha.
Pawson R; A'Hern R; Catovsky D
Leuk Lymphoma; 1996 Jun; 22(1-2):103-6. PubMed ID: 8724535
[TBL] [Abstract][Full Text] [Related]
6. Observations on the development of T-cell leukaemia in the patient successfully treated by interferon-alpha for typical hairy cell leukaemia (HCL).
Demeter J; Paloczi K
Leukemia; 1992 Nov; 6(11):1235-6. PubMed ID: 1290544
[No Abstract] [Full Text] [Related]
7. Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment.
Kampmeier P; Spielberger R; Dickstein J; Mick R; Golomb H; Vardiman JW
Blood; 1994 May; 83(10):2931-8. PubMed ID: 8180388
[TBL] [Abstract][Full Text] [Related]
8. Prolonged interferon-alpha-2b treatment of hairy cell leukemia patients.
Bourantas KL; Hatzimichael EC; Makis AC; Kapsali E; Tsiara S; Christou L; Seferiadis K
Eur J Haematol; 2000 May; 64(5):350-1. PubMed ID: 10863983
[No Abstract] [Full Text] [Related]
9. Clinical relevance of recombinant interferon-alpha 2a antibodies in patients with hairy cell leukemia.
Steis RG; Longo DL
J Interferon Res; 1994 Aug; 14(4):207-9. PubMed ID: 7822877
[No Abstract] [Full Text] [Related]
10. Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for hairy cell leukemia.
Stratta P; Canavese C; Dogliani M; Thea A; Degani G; Mairone L; Vercellone A
Ren Fail; 1993; 15(4):559-61. PubMed ID: 8210571
[TBL] [Abstract][Full Text] [Related]
11. Severe polymorphic erythema due to interferon α-2b during treatment of hairy cell leukemia.
Li C; Geng H; Ji L; Jiang Y; Ma X; Yin Q; Xiong H
J Int Med Res; 2019 Jul; 47(7):3453-3457. PubMed ID: 31248295
[TBL] [Abstract][Full Text] [Related]
12. Erythrocytosis in hairy cell leukaemia following therapy with interferon alpha.
Steis RG; VanderMolen LA; Lawrence J; Sing G; Ruscetti F; Smith JW; Urba WJ; Clark J; Longo DL
Br J Haematol; 1990 May; 75(1):133-5. PubMed ID: 2375913
[No Abstract] [Full Text] [Related]
13. Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia.
Spielberger RT; Dickstein JI; Le Beau MM; Larson RA; Daly KM; Vardiman JW; Golomb HM
Br J Haematol; 1993 Mar; 83(3):519-20. PubMed ID: 8485059
[No Abstract] [Full Text] [Related]
14. Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia.
Guerci AP; Guerci B; Lévy-Marchal C; Ongagna J; Ziegler O; Candiloros H; Guerci O; Drouin P
Lancet; 1994 May; 343(8906):1167-8. PubMed ID: 7910261
[No Abstract] [Full Text] [Related]
15. Reversible cardiomyopathy in a patient with hairy cell leukaemia.
Sucak GT; Haznedar R; Yalçin R
Postgrad Med J; 1998 May; 74(871):313-4. PubMed ID: 9713625
[No Abstract] [Full Text] [Related]
16. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
Habermann TM; Andersen JW; Cassileth PA; Bennett JM; Oken MM
Br J Haematol; 1992 Apr; 80(4):466-71. PubMed ID: 1581231
[TBL] [Abstract][Full Text] [Related]
17. Hairy cell leukemia: treatment results and association with secondary malignancy.
Kwong YL; Liang R; Chiu E; Chan DW; Chan TK
Am J Hematol; 1995 Apr; 48(4):291. PubMed ID: 7717384
[No Abstract] [Full Text] [Related]
18. Considerations on the pathogenesis of acute myeloid leukaemia in a splenectomized hairy cell leukaemia patient treated with interferon-alpha.
Demeter J; Turbucz P; Lehoczky D; Porzsolt F
Br J Haematol; 1994 Jan; 86(1):236. PubMed ID: 8011543
[No Abstract] [Full Text] [Related]
19. Successful treatment of hair cell leukemia with 2'-deoxycoformycin after failure of interferons alpha or beta.
Dutcher JP; Salva KM; Wiernik PH
Am J Clin Oncol; 1990 Aug; 13(4):290-3. PubMed ID: 2198792
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic advances in the treatment of hairy cell leukemia.
Andrey J; Saven A
Leuk Res; 2001 May; 25(5):361-8. PubMed ID: 11301103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
